Abstract: An organic semiconducting layer formulation containing an organic binder which has a permittivity, ?, at 1,000 Hz of 3.3 or less and a polyacene compound of Formula A: and processes for the preparation thereof and uses thereof in various electronic devices.
Type:
Grant
Filed:
November 25, 2004
Date of Patent:
November 30, 2010
Assignee:
Merck Patent GmbH
Inventors:
Beverley Anne Brown, Janos Veres, Remi Manouk Anemian, Richard Williams, Simon Dominic Ogier, Stephen William Leeming
Abstract: A manufacturing method for one of, or a mixture of, an optically active allylboron compound and racemic or optically active boryl cyclopropane, including a coupling reaction, in the presence of a catalyst, between allyl compound and diboron compound. It is preferred that a copper (I) complex is used as the catalyst. It is preferred that a counterion of the copper (I) complex is an alkoxide or a hydride. It is preferred that the copper (I) complex has a phosphine ligand. It is preferred that the phosphine ligand is a chiral phosphine ligand.
Abstract: The present invention relates to a synthetic method for terbinafine and analogues thereof using metal catalysts, preferably Ni(II) salts and/or complexes.
Type:
Grant
Filed:
March 4, 2005
Date of Patent:
November 23, 2010
Assignee:
F.I.S. Fabbrica Italiana Sintetici S.p.A.
Inventors:
Federico Della Negra, Cristiano Grandini, Mariano Stivanello
Abstract: The present invention features a chemoselective ligation reaction that can be carried out under physiological conditions. In general, the invention involves condensation of a specifically engineered phosphine, which can provide for formation of an amide bond between the two reactive partners resulting in a final product comprising a phosphine moiety, or which can be engineered to comprise a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine byproduct and producing a native amide bond in the final product. The selectivity of the reaction and its compatibility with aqueous environments provides for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).
Type:
Grant
Filed:
October 18, 2007
Date of Patent:
November 23, 2010
Assignee:
The Regents of the University of California
Abstract: The present invention is directed to fluoro silicone acrylates that are used in reaction either alone or with other monomers to make polymers that can modify the surface of hair skin or pigment. This makes them ideal for incorporation into pigmented products in personal care applications like make up and lipsticks.
Type:
Grant
Filed:
February 11, 2009
Date of Patent:
November 16, 2010
Inventors:
Anthony John O'Lenick, Jr., John Imperante
Abstract: Method and system for forming an anhydrous sterilant. In one embodiment, anhydrous peracetic acid is combined with carbon dioxide, wherein the carbon dioxide is in one of a liquid, solid, and supercritical state.
Abstract: A method for producing a polymeric material comprises reacting a first reactant with a second reactant. The first reactant comprises anhydrous phosphorous pentoxide and the second reactant comprises an alcohol. A method for producing a polymeric salt material comprises reacting a first reactant comprising an amine with a second reactant comprising a phosphate ester.
Abstract: A novel sulfonium borate complex, which can reduce the amount of fluorine ions produced during thermal cationic polymerization, and realize low-temperature, rapid curing properties in a thermal cationic polymerizable adhesive, is represented by the structure of the following formula (1). In the formula (1), R1 is an aralkyl group and R2 is a lower alkyl group. However, when R2 is a methyl group, R1 is not a benzyl group. X is a halogen atom, and n is an integer of 1 to 3.
Type:
Grant
Filed:
March 18, 2008
Date of Patent:
November 9, 2010
Assignees:
Sony Corporation, Sony Chemical & Information Device Corporation
Abstract: A process for treating a composition comprising one or more desired (hydro)halocarbons and one or more undesired sulphur containing impurities so as to reduce the concentration of at least one undesired sulphur containing impurity, the process comprising contacting the composition with an adsorbent comprising an acid stable molecular sieve having a pore size of from 2 to 10 ? and/or an activated carbon.
Abstract: A primary phosphine or a secondary phosphine is reacted with an ester compound selected from the group consisting of; a phosphate triester; a phosphonate diester; a sulfate diester; and a sulfonate ester; to form a phosphonium salt of formula (VII) wherein each of RQ, RX, RY, and RZ is independently hydrocarbyl and X? is a phosphate, phosphonate, sulfate, or sulfonate. These phosphonium salts may find utility in a wide range of applications, including as surfactants, as polar solvents (ionic liquids), as antimicrobial agents, and as a component of spinning finish in polyamide fiber processing.
Type:
Grant
Filed:
March 8, 2004
Date of Patent:
November 9, 2010
Assignee:
Cytec Technology Corp
Inventors:
Christine J. Bradaric-Baus, Yuehui Zhou
Abstract: A process for the production of a color-stable composition containing cardanol and cardol including (a) subjecting crude, cashew nutshell liquid to distillation to obtain a distillate: (b) reacting the distillate with boric acid to obtain a reaction mixture; and (c) subjecting the reaction mixture to distillation is provided. A method for the production of color-stable phenalkamines including (a) subjecting crude, cashew nutshell liquid to distillation to obtain a distillate; (b) reacting the distillate with boric acid to obtain a reaction mixture; (c) subjecting the reaction mixture to distillation to obtain a main fraction; and (d) reacting the main fraction with an aliphatic amine and formaldehyde to form a color-stable phenalkamine is also provided.
Abstract: Disclosed herein are novel di-aromatic compounds and methods for using various di-aromatic compounds for treatment and prevention of diseases and disorders related to estrogen receptors.
Type:
Grant
Filed:
November 8, 2005
Date of Patent:
November 2, 2010
Assignee:
ACADIA Pharmaceuticals Inc.
Inventors:
Roger Olsson, Lene Hyldtoft, Fabrice Piu, Magnus Gustafsson, Vladimir Sherbukhin, Birgitte Winther Lund
Abstract: To provide a novel fluorinated compound, a fluoropolymer and a method for producing the compound. A compound represented by the formula CF2?CFCF2C(X)(C(O)OZ)(CH2)nCR?CHR (wherein X is a hydrogen atom, a cyano group or a group represented by the formula —C(O)OZ, Z is a hydrogen atom or a C1-20 monovalent organic group, n is 0, 1, or 2, and R is a hydrogen atom or a C1-20 monovalent organic group), a method for producing it, and a fluoropolymer obtained by polymerizing the compound.
Abstract: A nanoparticle includes a chain oligomer section having a hydrophilic group and fluoroalkyl groups respectively at its opposite terminals, a three-dimensional silica network section, and an organic chain having fluorine or silicon, and is represented by the following formula (1): where R? is independent H or independent alkyl group; X is the hydrophilic group and is independent OH group, independent NCO group, independent NH2 group or the like; RF is the fluoroalkyl group having a carbon number of 2 to 10 and a molecular weight of 119 to 1000; 3D-SN is the three-dimensional silica network section; B is independent O, independent O?C—O or the like; E is O, O?C—O, NH—C?O or the like; G is [(CH2O)1—[Si(CH3)2O]k—(CH2O)1] or the like.
Abstract: This invention relates to polyoxometalates represented by the formula (An)m+[My(H2O)pXzZ2W18O66]m?1 or solvates thereof, wherein A represents a cation acting as counterion of the polyanion, n is the number of the cations A, m is the charge of the polyoxoanion, M represents a transition metal selected from Cu, Zn, Pd, Pt and mixtures thereof, y is the number of transition metals M and is a number from greater than 4 to less than 6, p is a number of water molecules and is a number from 0 to 10, X is a halide selected from F, Cl, Br, I and mixtures thereof, z is a number of halides and is a number from 0 to 6 and Z represents a heteroatom selected from SbIII, BiIII, AsIII, SeIV and TeIV.
Abstract: A tetrapyrollic photosensitizer compound having at least one pendant —CH2CH2CON(CH2CON(CH2COOH)2)2 or —N(CH2COOH)2 group or esters thereof said tetrapyrollic compound being a chlorin, bacteriochlorin, porphyrin, pyropheophorbide, purpurinimide, or bacteriopurpurinimide. Desirably the compound has the formula: or a pharmaceutically acceptable derivative thereof, wherein R1-R8 and R10 are various substituents and R9 is substituted or unsubstituted —CH2CH2CON(CH2CON(CH2COOH)2)2; or —N(CH2COOH)2. The invention also includes a method of treatment by photodynamic therapy by treatment with light after injecting the compound and a method of imaging by fluorescence after injection of the compound.
Type:
Grant
Filed:
February 19, 2009
Date of Patent:
October 26, 2010
Assignee:
Health Research, Inc.
Inventors:
Ravindra K. Pandey, Amy Gryshuk, Lalit Goswami, William Potter, Allan Oseroff
Abstract: The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.
Type:
Grant
Filed:
October 5, 2006
Date of Patent:
October 26, 2010
Assignee:
Rigel Pharmaceuticals, Inc.
Inventors:
Rajinder Singh, Ankush Argade, Donald Payan, Susan Molineaux, Sacha J. Holland, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Catherine Sylvain, Hui Li, Alexander B. Rossi
Abstract: A process for reducing the levels of undesirable impurities in a mesotrione sample is disclosed, said process comprising the steps of: (i) forming a mesotrione enolate solution in an aqueous solvent, (ii) carrying out one or more purification processes, and (iii) crystallizing the purified mesotrione out of solution.
Type:
Grant
Filed:
October 1, 2004
Date of Patent:
October 26, 2010
Assignee:
Syngenta Crop Protection, Inc.
Inventors:
Julie Marie Wichert, Alan Henry Benke, Regine Laure Guidetti-Grep
Abstract: The invention relates to compounds having the general formula (I), the method of preparation thereof and the use thereof in organic radical synthesis. The invention also relates to compounds having the formula (II), the method of preparation thereof and a method for preparing compounds having the formula (VIII).
Type:
Grant
Filed:
August 6, 2008
Date of Patent:
October 26, 2010
Assignee:
Centre National de la Recherche Scientifique (CNRS)